
Executives from Atlantic Research Group discuss the importance of CRAs in rare disease clinical trials.
Paul Bishop is CEO, Atlantic Research Group (ARG), and can be reached at pbishop@atlanticresearchgroup.com Lyle Camblos is Managing Partner, Atlantic Research Group (ARG) and can be reached at lcamblos@atlanticresearchgroup.com

Published: August 2nd 2017 | Updated: